Bexion Pharmaceuticals

Bexion Pharmaceuticals company information, Employees & Contact Information

Poised to Deliver Breakthroughs in Oncology and CNS Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS. The company’s lead compound, BXQ-350, is a novel S1P modulator. With our highly experienced biotech leadership team and expertise in Oncology, we are urgently progressing our pipeline to develop life-changing oncology therapies on our path to becoming a leading biotech/pharmaceutical company. To learn more about Bexion Pharmaceuticals, please visit Bexionpharma.com or call (859) 446-7386.
Looking for a particular Bexion Pharmaceuticals employee's phone or email?

Bexion Pharmaceuticals Questions

News

Bexion Pharmaceuticals, Inc. Awarded Grant from The Michael J. Fox Foundation to Advance BXQ-350 - PR Newswire

Bexion Pharmaceuticals, Inc. Awarded Grant from The Michael J. Fox Foundation to Advance BXQ-350 PR Newswire

Phase 1b/2 Study of BXQ-350 in Metastatic Colorectal Cancer Completes Enrollment - Targeted Oncology

Phase 1b/2 Study of BXQ-350 in Metastatic Colorectal Cancer Completes Enrollment Targeted Oncology

Bexion Pharmaceuticals, Inc. Announces Poster Presentation at ASCO GI 2025 - PR Newswire

Bexion Pharmaceuticals, Inc. Announces Poster Presentation at ASCO GI 2025 PR Newswire

Patient No. 1 and the cancer trial here that just might change everything - Cincinnati Enquirer

Patient No. 1 and the cancer trial here that just might change everything Cincinnati Enquirer

Bexion Pharmaceuticals, Inc. Announces Completion of Enrollment in Open Label Portion of Phase 1b/2 ASIST Study in mCRC - PR Newswire

Bexion Pharmaceuticals, Inc. Announces Completion of Enrollment in Open Label Portion of Phase 1b/2 ASIST Study in mCRC PR Newswire

Bexion Pharmaceuticals Announces Leadership Additions - PR Newswire

Bexion Pharmaceuticals Announces Leadership Additions PR Newswire

Bexion Pharmaceuticals, Inc. Appoints Dr. Tariq Arshad as Chief Medical Officer - PR Newswire

Bexion Pharmaceuticals, Inc. Appoints Dr. Tariq Arshad as Chief Medical Officer PR Newswire

Charles R. Scheper, Chairman of Bexion Pharmaceuticals Board, Named Great Living Cincinnatian - PR Newswire

Charles R. Scheper, Chairman of Bexion Pharmaceuticals Board, Named Great Living Cincinnatian PR Newswire

Bexion Pharmaceuticals, Inc. Appoints Dr. Catherine Pearce, DHSc, MBA, to Board of Directors - PR Newswire

Bexion Pharmaceuticals, Inc. Appoints Dr. Catherine Pearce, DHSc, MBA, to Board of Directors PR Newswire

Top Bexion Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant